Login to Your Account



Avita Medical's Recell spray-on-skin meets endpoints in pivotal trial

By Tamra Sami
Staff Writer

Friday, May 19, 2017

PERTH, Australia – Avita Medical Ltd. plans to submit its Recell spray-on-skin premarket approval application to the FDA in a few weeks following positive results from its pivotal trial.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription